March Bio | 4biocapital

top of page

HOME
ABOUT US
- SOCIAL IMPACT
STRATEGY
TEAM
PORTFOLIO
- CURRENT PORTFOLIO
- PAST PORTFOLIO
NEWSROOM
CONTACT
More

Use tab to navigate through the menu items.

NEWSROOM

Oct 23, 2024

4BIO Capital leads oversubscribed $28.4 million Series A financing of March Biosciences

4BIO Capital leads oversubscribed $28.4 million Series A financing of March Biosciences

ARCHIVE

January 2025 1 post
November 2024 3 posts
October 2024 3 posts
May 2024 1 post
April 2024 1 post
March 2024 1 post
January 2024 1 post
November 2023 2 posts
August 2023 1 post
June 2023 1 post
May 2023 2 posts
December 2022 2 posts
November 2022 1 post
October 2022 1 post
September 2022 2 posts
June 2022 2 posts
April 2022 1 post
March 2022 1 post
February 2022 1 post
January 2022 2 posts

SEARCH BY TAGS

FOLLOW US

4BIO Capital is a trading name of 4BIO Partners LLP which is authorised and regulated by the Financial Conduct Authority (Reference Number 842764)

4BIO Partners LLP is an SEC Registered Investment Advisor number 801-121342

© 2015-2024 by 4BIO Partners LLP

bottom of page